《山东华鹏关于子公司获得政府补助的进展公告》 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 截至2025年11月28日收盘，ST华鹏（603021）报收于5.27元，较前一交易日下跌0.19%，最新总市值为 16.86亿元。该股当日开盘5.27元，最高5.39元，最低5.25元，成交额达2867.28万元，换手率为1.68%。 公司近日发布公告称，其全资子公司安庆华鹏长江玻璃有限公司收到2025年中央财政大气污染防治资金 第二批支持资金，项目为"安庆华鹏玻璃窑炉废气治理提升改造项目"。2025年11月27日收到支持资金 930万元，占公司最近一期经审计净资产的16.88%，该补助属于与资产相关的政府补助。此前已于2025 年10月20日收到465万元。公司将依据会计准则进行确认和处理，具体影响以审计结果为准。 最新公告列表 ...

证券代码：603021 证券简称：ST 华鹏 公告编号：临 2025-067 山东华鹏玻璃股份有限公司 关于子公司获得政府补助的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、获得补助的基本情况及进展 2025 年 11 月 27 日，安庆华鹏收到支持资金 930 万元，占公司最近一期经 审计净资产的 16.88%，上述政府补助属于与资产相关的政府补助。后续如陆续 收到支持资金，公司会依照相关法律法规的要求及时履行信息披露义务。 二、补助的类型及其对上市公司的影响 公司根据《企业会计准则第16号—政府补助》的有关规定，确认上述事项并 划分补助类型。上述政府补助未经审计，具体会计处理及对公司2025年度以及以 后年度损益的影响，最终以审计机构年度审计确认后的结果为准。敬请广大投资 者注意投资风险。 特此公告。 山东华鹏玻璃股份有限公司董事会 2025 年 11 月 28 日 1 / 1 山东华鹏玻璃股份有限公司（以下简称"公司"）全资子公司安庆华鹏长江 玻璃有限公司（以下简称"安庆华鹏"）前期收到安徽省财政厅与安徽 ...

近日，上述大修项目已具备较为完整的工艺条件及相关的配套设施，经过多次调试各项指标已达到投产 要求，并投入生产。 该项目的投产符合公司产能规划的战略目标，有利于公司进一步提升产量和市场占有率。该项目未来运 营将受市场风险、经营管理风险、技术风险等多种因素的影响，敬请广大投资者注意投资风险。 全资子公司大修项目投产的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 山东华鹏玻璃股份有限公司（以下简称"公司"）全资子公司安庆华鹏长江玻璃有限公司因政府环保要求 及窑炉运行接近使用寿命末期，需对窑炉及相关设备设施进行升级改造，于2025年7月初进行停产大 修，具体内容详见公司于2025年7月8日在指定信息披露媒体上披露的《关于全资子公司大修改造的公 告》（公告编号：临2025-039）。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603021 证券简称：ST华鹏 公告编号：临2025-066 山东华鹏玻璃股份有限公司关于 特此公告。 山东华鹏玻璃股份有限公司董事会 2025年11月25日 ...

分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]

ST华鹏（603021）(603021.SH)发布公告，公司全资子公司安庆华鹏长江玻璃有限公司因政府环保要求 及窑炉运行接近使用寿命末期，需对窑炉及相关设备设施进行升级改造，于2025年7月初进行停产大 修。近日，上述大修项目已具备较为完整的工艺条件及相关的配套设施，经过多次调试各项指标已达到 投产要求，并投入生产。 ...

智通财经APP讯，ST华鹏(603021.SH)发布公告，公司全资子公司安庆华鹏长江玻璃有限公司因政府环 保要求及窑炉运行接近使用寿命末期，需对窑炉及相关设备设施进行升级改造，于2025年7月初进行停 产大修。近日，上述大修项目已具备较为完整的工艺条件及相关的配套设施，经过多次调试各项指标已 达到投产要求，并投入生产。 ...

山东华鹏玻璃股份有限公司（以下简称"公司"）全资子公司安庆华鹏长江玻 璃有限公司因政府环保要求及窑炉运行接近使用寿命末期，需对窑炉及相关设备 设施进行升级改造，于 2025 年 7 月初进行停产大修，具体内容详见公司于 2025 年 7 月 8 日在指定信息披露媒体上披露的《关于全资子公司大修改造的公告》（公 告编号：临 2025-039）。 近日，上述大修项目已具备较为完整的工艺条件及相关的配套设施，经过多 次调试各项指标已达到投产要求，并投入生产。 该项目的投产符合公司产能规划的战略目标，有利于公司进一步提升产量和 市场占有率。该项目未来运营将受市场风险、经营管理风险、技术风险等多种因 素的影响，敬请广大投资者注意投资风险。 特此公告。 山东华鹏玻璃股份有限公司董事会 证券代码：603021 证券简称：ST 华鹏 公告编号：临 2025-066 山东华鹏玻璃股份有限公司 关于全资子公司大修项目投产的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 2025 年 11 月 25 日 1 / 1 ...

Investment Rating - The report does not provide a specific investment rating for the industry or companies mentioned [1]. Core Insights - The report highlights several new stock listings and trading activities scheduled for November 18, 2025, including companies such as Jingchuang Electric (12.10), Beikang Testing (6.70), and Nanguang Digital (5.69) [1]. - It also mentions various corporate actions such as tender offers, cash options, and acquisition requests, indicating active market movements [1]. Summary by Relevant Sections - **New Stock Listings**: Companies like Jingchuang Electric, Beikang Testing, and Nanguang Digital are set to debut on the market with respective prices of 12.10, 6.70, and 5.69 [1]. - **Corporate Actions**: The report details several corporate actions including a tender offer for Tianpu Co. (605255) from November 20 to December 19, 2025, and cash options for Hangqi Wheel B (200771) from November 19 to November 25, 2025 [1]. - **Market Alerts**: It lists companies experiencing significant fluctuations, such as Moen Electric (002451) and Huasheng Lithium Battery (688353), indicating potential investment risks and opportunities [1].

Market Overview - The home goods sector experienced a decline of 0.4% on November 18, with Longzhu Technology leading the drop [1] - The Shanghai Composite Index closed at 3939.81, down 0.81%, while the Shenzhen Component Index closed at 13080.49, down 0.92% [1] Stock Performance - Notable gainers in the home goods sector included: - Huaci Co., Ltd. (Code: 001216) with a closing price of 20.61, up 9.98% and a trading volume of 289,700 shares, totaling 586 million yuan [1] - Yayi Technology (Code: 301113) closed at 26.67, up 3.09% with a trading volume of 27,900 shares, totaling 73.35 million yuan [1] - Hango Group (Code: 001221) closed at 59.44, up 2.48% with a trading volume of 26,900 shares [1] - Major decliners included: - Longzhu Technology (Code: 920445) closed at 12.35, down 7.84% with a trading volume of 112,700 shares, totaling 142 million yuan [2] - Deyi Culture (Code: 300640) closed at 7.58, down 5.49% with a trading volume of 347,800 shares, totaling 266 million yuan [2] - ST Huapeng (Code: 603021) closed at 5.62, down 5.07% with a trading volume of 122,800 shares [2] Capital Flow - The home goods sector saw a net outflow of 407 million yuan from institutional investors, while retail investors contributed a net inflow of 465 million yuan [2] - Detailed capital flow for selected stocks showed: - Hango Group had a net outflow of 15.19 million yuan from institutional investors [3] - Filinger (Code: 603226) experienced a net inflow of 15.04 million yuan from institutional investors [3] - Meike Home (Code: 600337) had a net inflow of 7.90 million yuan from institutional investors [3]

Core Viewpoint - The stock of Shandong Huapeng Glass Co., Ltd. experienced abnormal trading fluctuations, with a closing price increase exceeding 12% over three consecutive trading days, prompting a notice to investors regarding potential risks [2][3]. Group 1: Stock Trading Abnormalities - The company's stock price increased by more than 12% on November 13, 14, and 17, 2025, indicating abnormal trading activity as per Shanghai Stock Exchange regulations [2][3]. - The company reported a net loss of 96.05 million yuan for the first nine months of 2025, with a negative net asset value of 40.95 million yuan as of September 30, 2025 [2][8]. Group 2: Company Operations and Major Events - The company confirmed that its production and operational activities are normal, with no significant changes in the internal or external business environment [4]. - There are no undisclosed major events affecting the company's stock trading, including asset restructuring or bankruptcy proceedings [5][10]. Group 3: Media Reports and Market Rumors - The company found no media reports or market rumors that could impact its stock price, and all previously disclosed information remains accurate without the need for corrections [6][9]. Group 4: Bank Account Freezing - The company disclosed that its subsidiary, Shandong Huapeng Shidao Glass Products Co., Ltd., has had three bank accounts frozen, totaling 107,116.24 yuan, which is 0.19% of the company's latest audited net assets [13][14]. - The freezing of accounts is related to a legal dispute with a former legal advisor concerning a contract dispute from 2019, but the company has not received formal legal documents regarding this matter [14][15].